Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens
接受基于拉替拉韦和不基于拉替拉韦的联合抗逆转录病毒疗法治疗的个体中癌症的发生率和总体死亡风险
期刊:Hiv Medicine
影响因子:3.2
doi:10.1111/hiv.12557
Cozzi-Lepri, A; Zangerle, R; Machala, L; Zilmer, K; Ristola, M; Pradier, C; Kirk, O; Sambatakou, H; Fätkenheuer, G; Yust, I; Schmid, P; Gottfredsson, M; Khromova, I; Jilich, D; Flisiak, R; Smidt, J; Rozentale, B; Radoi, R; Losso, M H; Lundgren, J D; Mocroft, A
